Bronchitis can be treated with a 'flash-freeze' icy blast to the lungs in new 30 minute procedure
The RejuvenAir procedure is being offered as part of a trial at the Royal Brompton & Harefield NHS Foundation Trust and the Chelsea & Westminster Hospital NHS Foundation Trust. (Source: the Mail online | Health)
Source: the Mail online | Health - August 15, 2020 Category: Consumer Health News Source Type: news

Covid lockdown: England sees fewer cases of colds, flu, and bronchitis, BMJ
Figures published by the Royal College of General Practitioners, derived from data from 500 practices across England, suggest that lockdown and physical distancing measures to prevent the spread of covid-19 were the probable cause of the trend. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 13, 2020 Category: Consumer Health News Source Type: news

Cold, flu and bronchitis infections fell 'well below average' during coronavirus lockdown
A report by the Royal College of GPs shows rates for these viruses fell drastically when the UK locked down in late March. Ten times fewer were going to their GP with a cold last month. (Source: the Mail online | Health)
Source: the Mail online | Health - August 10, 2020 Category: Consumer Health News Source Type: news

TREMFYA ® (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis
HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA® (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] TREMFYA is the first treatment approved for active PsA that selectively inhibits interleukin (IL)-23, a naturally occurring cytokine that is involved in normal inflammatory and immune responses associated with the symptoms of PsA. The safety and efficacy of TREMFYA in PsA have b...
Source: Johnson and Johnson - July 14, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Follow-up appointments for children hospitalized for bronchiolitis may not be needed
(Intermountain Medical Center) A new study at Intermountain Primary Children's Hospital in Salt Lake City has found that follow-up appointments for hospitalized children treated for childhood bronchitis are often not necessary, and that switching from mandatory to 'as-needed' follow-up care can save families from unnecessary medical care and expense - and may help guide treatment during the COVID-19 pandemic. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 6, 2020 Category: International Medicine & Public Health Source Type: news

Children ’ s Robitussin And Dimetapp Cough Medicines Recalled For Potential Overdose Risks
(CNN) — Parents take note: GlaxoSmithKline Consumer Healthcare has voluntarily recalled three lots of its children’s cough syrups — Children’s Robitussin Honey Cough and Chest Congestion DM and Children’s Dimetapp Cold and Cough — due to the products having incorrect dosing cups in their packaging. That means parents might accidentally overdose a child by putting too much syrup in the cup. Symptoms of overdose of either product may include impaired coordination, elevated blood pressure, dizziness, seizure, nausea, vomiting, constipation, diarrhea, abdominal pain, hallucinations, among ot...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 19, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News CNN Cough Syrup Recall Source Type: news

Subcutaneous Daratumumab Combination Resulted in Deep and Rapid Hematologic Responses and Improved Clinical Outcomes in the Treatment of Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
RARITAN, NJ, June 13, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the first randomized Phase 3 study investigating subcutaneous daratumumab[i] in the treatment of patients with newly diagnosed light chain (AL) amyloidosis, a rare and potentially fatal disease.[1],[2] The data demonstrated subcutaneous daratumumab in combination with cyclophosphamide, bortezomib, and dexamethasone (D-CyBorD) resulted in a higher hematologic complete response rate (CR), (53 percent vs. 18 percent [P
Source: Johnson and Johnson - June 15, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Inherent Flaws in COVID-19 Testing Mean Some of Those Infected Don ’t Get the Treatment They Need
In late February, several weeks before the coronavirus outbreak shut down American cities and rose to the level of a national crisis, Kerri Rawson began to feel sick. “I was hit out of nowhere with what feels like the flu at first,” says Rawson, who also has asthma and takes cardiac medication for high-blood pressure. “You’re fine, and then all of a sudden you have a fever below 100°F and chest congestion.” Rawson is a 41-year-old writer and mother of two in Florida. (You may recognize her name from her 2019 memoir, about growing up as the daughter of a serial killer.) Her fever lasted for...
Source: TIME: Health - May 8, 2020 Category: Consumer Health News Authors: Zach Schonfeld Tags: Uncategorized COVID-19 feature Source Type: news

Janssen Announces Submission of Two Applications to U.S. FDA Seeking Approval of SIMPONI ARIA ® (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
HORSHAM, PA, April 24, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of two supplemental Biologics License Applications (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of SIMPONI ARIA® (golimumab) for the treatment of polyarticular juvenile idiopathic arthritis (pJIA) and juvenile psoriatic arthritis (jPsA), in patients two years of age and older in combination with methotrexate. If approved for these indications, SIMPONI ARIA would be the first anti-tumor necrosis factor (TNF)-alpha biologic agent administered by intravenous infusion av...
Source: Johnson and Johnson - April 24, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Smoking Marijuana Even Occasionally Raises Risk Of Coronavirus Complications, Experts Say
(CNN) — If you’re smoking weed to ease your stress during the coronavirus pandemic, experts say it’s time to think twice. Smoking marijuana, even occasionally, can increase your risk for more severe complications from Covid-19, the disease caused by the novel coronavirus. “What happens to your airways when you smoke cannabis is that it causes some degree of inflammation, very similar to bronchitis, very similar to the type of inflammation that cigarette smoking can cause,” said pulmonologist Dr. Albert Rizzo, chief medical officer for the American Lung Association. “Now you have some air...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 10, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Coronavirus Marijuana Source Type: news

Coronavirus Recovery Story: Marshfield Man Beats Severe COVID-19 Case
MARSHFIELD (CBS) – Across the United States, more than 24,000 people have recovered from coronavirus. One of them is a South Shore man who just left the hospital after a serious fight against the virus. Curtis Akins is back home in Marshfield now, but the 55-year-old is still tethered to an oxygen tank. Just a couple weeks ago, he wasn’t sure he would ever see his home again. “The first 3 or 4 days I’d say were the scariest moments of my life,” he said. Medical staff cheered Curtis Akins as he was released from South Shore Hospital, and he cheered them right back. (Image courtesy of South Shor...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 9, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated Local Bill Shields Coronavirus South Shore Hospital Source Type: news

Understanding end-stage COPD: Coping strategies for patients and their loved ones
(Natural News) Chronic obstructive pulmonary disease (COPD) refers to a cluster of potentially fatal respiratory conditions. It is marked by breathlessness, inflammation, airway obstruction and significant bronchial damage. Many of the chronic respiratory diseases classified under COPD, such as emphysema and chronic bronchitis, are primarily caused by exposure to cigarette smoke. However, COPD can also... (Source: NaturalNews.com)
Source: NaturalNews.com - March 30, 2020 Category: Consumer Health News Source Type: news

Similarities and differences between emphysema and chronic bronchitis, two conditions that fall under COPD
(Natural News) Chronic obstructive pulmonary disease (COPD) refers to a group of life-threatening diseases that severely affect the lungs, causing breathlessness, inflammation, airway obstruction and significant bronchial damage over time. Many of the chronic respiratory diseases classified under COPD are primarily caused by exposure to tobacco smoke, but they can also be exacerbated by factors such as air quality, existing cardiovascular... (Source: NaturalNews.com)
Source: NaturalNews.com - March 24, 2020 Category: Consumer Health News Source Type: news

Coronavirus: Debunking Myths And Misinformation
(CNN) — As the novel coronavirus — and panic about the coronavirus — continues to spread around the world, so too are bogus claims, conspiracy theories and misinformation about the disease. There’s so much inaccurate information floating around out there that the World Health Organization is calling it an “infodemic.” In perhaps the clearest sign of the times, WHO has joined TikTok to help set the record straight. Read: Coronavirus – What You Should And Shouldn’t Do The myths exist both on the fringes of the internet and in more mainstream outlets. And while social media...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 4, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health CNN Coronavirus Source Type: news

The 4 stages of COPD: Pay attention to your symptoms and make lifestyle changes to prevent it
(Natural News) COPD, or chronic obstructive pulmonary disease, is an umbrella term referring to a group of progressive lung diseases. Among the common diseases classified under COPD are emphysema and chronic bronchitis. According to the American Lung Association, COPD is the third leading cause of death in the US, only behind cancer and heart disease.... (Source: NaturalNews.com)
Source: NaturalNews.com - February 27, 2020 Category: Consumer Health News Source Type: news

Raspberries: A potential treatment for COPD?
(Natural News) Chronic obstructive pulmonary disease (COPD) refers to a group of progressive lung diseases, including common ones like emphysema and chronic bronchitis. According to the American Lung Association, COPD is the third leading cause of death in the US, behind cancer and heart disease. More than 15.3 million Americans have been diagnosed with COPD,... (Source: NaturalNews.com)
Source: NaturalNews.com - February 24, 2020 Category: Consumer Health News Source Type: news

Common Antibiotics Linked To Increased Risk Of Birth Defects, Study Says
(CNN) — Taking some common antibiotics during the first trimester of pregnancy was linked with higher risk of birth defects, according to a new study. The study, published Wednesday in the medical journal BMJ, found an increased risk of birth defects in the children of women who were prescribed macrolides during the first three months of pregnancy compared to mothers who were prescribed penicillin. Macrolide antibiotics include erythromycin, clarithromycin and azithromycin, and they are used to treat infections, such as pneumonia, bronchitis and urinary, skin and sexually transmitted diseases. They are often prescrib...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 20, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Source Type: news

He Had Trouble Breathing, and Inhalers Didn ’t Help. What Was Going On?
He ’d had episodes of coughing and wheezing since he was a boy. Now in his 60s, he worried his symptoms would force him to quit working. (Source: NYT Health)
Source: NYT Health - February 12, 2020 Category: Consumer Health News Authors: Lisa Sanders, M.D. Tags: Bronchitis Plastic bronchitis Lymph Nodes and Lymphatic System Source Type: news

Janssen Announces Submission to U.S. FDA for New DARZALEX ® (Daratumumab)-Based Combination Regimen for Patients with Relapsed/Refractory Multiple Myeloma
RARITAN, NJ, February 10, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of DARZALEX® (daratumumab) in combination with Kyprolis® (carfilzomib) and dexamethasone (DKd) for relapsed/refractory multiple myeloma. The sBLA is supported by results from the Phase 3 CANDOR study, which compared treatment with DKd to carfilzomib and dexamethasone (Kd) in patients with multiple myeloma who relapsed after one to three prior lines of therapy. “W...
Source: Johnson and Johnson - February 10, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Can non-smokers develop chronic obstructive pulmonary disease (COPD)?
(Natural News) Chronic obstructive pulmonary disease (COPD) refers to a group of conditions that can block airflow and cause a wide variety of breathing-related problems, including emphysema and bronchitis. They cause the body to create more mucus and trigger inflammation, which can cause parts of the lungs to become significantly less elastic and damages the... (Source: NaturalNews.com)
Source: NaturalNews.com - February 5, 2020 Category: Consumer Health News Source Type: news

Boston screens plane, preps hospitals amid national coronavirus outbreak
Logan Airport screened one flight from Hong Kong and local hospitals are taking a number of other precautions in the midst of a national coronavirus outbreak.   The state does not have a single confirmed case of the virus, which presents as mild to moderate upper-respiratory tract illnesses and sometimes lower-respiratory tract illnesses, such as pneumonia or bronchitis. Yet public health officials and state legislators are preparing should the state en counter a case.  The Department of Public… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 27, 2020 Category: Biotechnology Authors: Jessica Bartlett Source Type: news

Logan Airport Not Currently Screening Passengers For Coronavirus
BOSTON (CBS/CNN) – A new Chinese coronavirus, a cousin of the SARS virus, has infected more than 200 people since the outbreak began in Wuhan, China, in December. Boston’s Logan Airport is not currently screening passengers for the illness, a spokesman for Customs and Border Protection told WBZ-TV. That’s because there are no direct flights to Boston from that region. Additional health screening for coronavirus is in place at JFK Airport in New York, San Francisco International Airport and Los Angeles International Airport. The agency said the CDC has determined that coronavirus presents a low risk to the...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 21, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Coronavirus Logan Airport Source Type: news

Drug designed to break up PHLEGM for patients with bronchitis 'could slow down Parkinson's
Researchers at University College London and the Royal Free Hospital tested ambroxol on 17 Parkinson's sufferers over six months. Results were published in the journal JAMA Neurology. (Source: the Mail online | Health)
Source: the Mail online | Health - January 14, 2020 Category: Consumer Health News Source Type: news

Medical News Today: Is it bronchitis or pneumonia?
Bronchitis and pneumonia are two illnesses that people often confuse because they have many overlapping symptoms. Learn more about the differences here and when to see a doctor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 7, 2020 Category: Consumer Health News Tags: Respiratory Source Type: news

Antimicrobial Stewardship With a Collaborative Team
According to the Centers for Disease Control and Prevention (CDC), over 70% of patients in post-acute and long-term care (PALTC) settings are treated with one or more courses of antibiotics each year. Unfortunately, between 40% and 70% of these antibiotic prescriptions in PALTC are either inappropriate (empiric use of an antibiotic for a drug-resistant organism) or unnecessary (treating asymptomatic bacteria or viral bronchitis with an antibiotic). (Source: Caring for the Ages)
Source: Caring for the Ages - December 25, 2019 Category: Health Management Authors: Elizabeth Galik, Richard Stefanacci Tags: Caring Collaborative Source Type: news

Vaping linked with long-term risk of respiratory disease in new study
Vaping or using e-cigarettes for a long period of time may be associated with an increased risk of respiratory diseases, including chronic obstructive pulmonary disease or COPD, chronic bronchitis and asthma, according to a new study. (Source: CNN.com - Health)
Source: CNN.com - Health - December 16, 2019 Category: Consumer Health News Source Type: news

New Study Offers First Evidence Of Vaping's Long-Term Risks
The study finds that e-cigarettes are linked to increased risk of chronic lung diseases including emphysema, chronic bronchitis and COPD, as well as weakened immune defenses. (Source: NPR Health and Science)
Source: NPR Health and Science - December 16, 2019 Category: Consumer Health News Authors: Allison Aubrey Source Type: news

Vaping Linked With Long-Term Risk Of Respiratory Disease In New Study
(CNN) — Vaping or using e-cigarettes for a long period of time was associated with an increased risk of respiratory diseases — including chronic obstructive pulmonary disease or COPD, chronic bronchitis and asthma — in a new study. The study, published in the American Journal of Preventive Medicine on Monday, is among the first bodies of research to examine the link between e-cigarette use and respiratory disease in the long-term, by analyzing e-cigarette use and respiratory disease during a three-year period. “I was a little surprised that we could find evidence on incident lung disease in the long...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 16, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Vaping Source Type: news

Vaping Damages Your Lungs, But Is Still Safer Than Smoking, a Long-Term Study Suggests
This study actually does support the harm reduction potential of e-cigarettes,” says Andy Tan, an assistant professor of population sciences at Dana-Farber Cancer Institute who has studied e-cigarettes. “Yes, vaping is associated with about 29% to 31% higher odds of subsequent lung disease within two to three years than not vaping—but compare this with the 156% higher odds of using combustible tobacco than not smoking.” For the purposes of the study, Glantz and his co-author combined four conditions—chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema and asthma—in...
Source: TIME: Health - December 16, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized E-Cigarettes embargoed study Lung Disease Research vaping Source Type: news

Vaping Could Up Risks for Asthma, COPD and Other Lung Diseases
MONDAY, Dec. 16, 2019 -- As if the news on vaping wasn't bad enough, a new study suggests that e-cigarette users are also at significantly higher risk of chronic lung diseases such as asthma, bronchitis, emphysema and COPD. Those risks rose even... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 16, 2019 Category: General Medicine Source Type: news

Medical News Today: Signs and symptoms of bronchitis
Bronchitis causes inflammation of the airways within the lungs. Find out about the symptoms of bronchitis, how it develops, and the treatment options available. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 9, 2019 Category: Consumer Health News Tags: Respiratory Source Type: news

Medical News Today: How long does bronchitis take to go away?
Bronchitis is an inflammatory condition affecting the lungs. Here we look at the differences between acute and chronic bronchitis, how long each type may last, and when to see a doctor for treatment. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 22, 2019 Category: Consumer Health News Tags: Pulmonary System Source Type: news

Swiftly Ending Tobacco Epidemic Requires Government Action, Not Empty Promises
By Mark HurleyWASHINGTON DC, Oct 23 2019 (IPS) New information published in the Morbidity and Mortality Weekly Report shows that action taken by just 11 countries – most of them low- or middle-income – has resulted in 20 million fewer adult tobacco users in 2017 compared with 2008. Seventy percent of the world’s tobacco users live in low- and middle-income countries. This promising progress is a testament to strong government action and its effects are far reaching. Between 2008 and 2017, over 53 million fewer adults were exposed to secondhand smoke in indoor public places like restaurants, government bu...
Source: IPS Inter Press Service - Health - October 23, 2019 Category: International Medicine & Public Health Authors: Mark Hurley Tags: Development & Aid Editors' Choice Featured Global Global Governance Headlines Health Inequity IPS UN: Inside the Glasshouse Poverty & SDGs TerraViva United Nations Source Type: news

In a First, FDA Endorses Brand of Tobacco Pouches as a ‘Reduced Risk’ Alternative to Cigarettes
(WASHINGTON) — For the first time, U.S. health regulators have endorsed a brand of tobacco pouches as less harmful than cigarettes, a decision that could open the door to other less risky options for smokers. The milestone announcement on Tuesday from the Food and Drug Administration marks the government’s first backing of a so-called “reduced risk” tobacco product. FDA regulators stressed, though, that the Swedish Match pouches are not safe, just less harmful, and that all tobacco products pose risks. The pouches will still bear mandatory government warnings that they can cause mouth cancer, gum di...
Source: TIME: Health - October 22, 2019 Category: Consumer Health News Authors: MATTHEW PERRONE / AP Tags: Uncategorized FDA onetime Smoking Source Type: news

Minimally Invasive System Aims to Relieve Symptoms for Patients with Chronic Bronchitis
“Imagine somebody that gets bronchitis every day, with a cough so severe that they can’t talk in full sentences, they can’t sleep at night, and they can’t walk a decent distance,” said Jon Waldstreicher, MD, CEO of Gala Therapeutics, in an interview with MD+DI. Although someone with this condition might present to physicians with normal lung function, their chronic cough and mucous production negatively affects their quality of life. Until now, there has been no way to treat these debilitating symptoms effectively, even with medicatio...
Source: MDDI - October 9, 2019 Category: Medical Devices Authors: Susan Shepard Tags: Design Source Type: news

New Clinical Results from RheOx(TM) System for Chronic Bronchitis to be Presented at European Respiratory Society (ERS) International Congress
MENLO PARK, Calif., Sept. 26, 2019 -- (Healthcare Sales & Marketing Network) -- Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, today announced that clinical results and a patient case involving its RheOxTM Bronc... Devices Gala Therapeutics, RheOx system, Bronchial Rheoplasty, Chronic Bronchitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 26, 2019 Category: Pharmaceuticals Source Type: news

Health Tip: Preventing Bronchitis
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 23, 2019 Category: Respiratory Medicine Tags: Pulmonology, FYI, Source Type: news

Health Tip: Preventing Bronchitis
-- Bronchitis is an inflammation of the bronchial tube lining, says Mayo Clinic. People who have bronchitis often cough up thick, discolored mucus. Though complications are rare, bronchitis can lead to pneumonia in some people. To help prevent... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 23, 2019 Category: General Medicine Source Type: news

Health Tip: Preventing Bronchitis
Title: Health Tip: Preventing BronchitisCategory: Health NewsCreated: 9/23/2019 12:00:00 AMLast Editorial Review: 9/23/2019 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - September 23, 2019 Category: Respiratory Medicine Source Type: news

Gala Therapeutics Receives FDA Breakthrough Device Designation for the Minimally Invasive RheOx(TM) System for Chronic Bronchitis
MENLO PARK, Calif., Sept. 16, 2019 -- (Healthcare Sales & Marketing Network) -- Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, announced the U.S. Food and Drug Administration (FDA) granted Breakthrough Device De... Devices Gala Therapeutics, RheOx system, Bronchial Rheoplasty, Chronic Bronchitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 16, 2019 Category: Pharmaceuticals Source Type: news

Gala Therapeutics Receives CE Mark for its Minimally Invasive RheOx(TM) System for Chronic Bronchitis
First-of-its-kind RheOx device designed to reduce mucus-producing cells and improve quality of life MENLO PARK, Calif., Sept. 4, 2019 -- (Healthcare Sales & Marketing Network) -- Gala Therapeutics, Inc. (Gala) today announced that its RheOx™ system has... Devices, Regulatory Gala Therapeutics, RheOx, Bronchial Rheoplasty, Chronic Bronchitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 4, 2019 Category: Pharmaceuticals Source Type: news

Medical News Today: Everything you need to know about chest infections
There are several types of chest infections, including bronchitis, pneumonia, and tuberculosis. Learn more about the symptoms and treatment options in this article. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 15, 2019 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news

Pediatrician intervention may help parents quit smoking, study says
Parents who smoke put their children and others around them at risk for bronchitis, pneumonia and a variety of other ailments. A smoking cessation program has shown some success in helping them quit, researchers report. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 12, 2019 Category: Consumer Health News Source Type: news

Health Tip: Dealing With a Chronic Cough
-- A chronic cough is defined as one that lasts more than eight weeks, says Cleveland Clinic. The clinic mentions a few treatment options: For pneumonia or bronchitis, antibiotics such as Azithrocin and Ceftin may be prescribed. For post-nasal... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 12, 2019 Category: General Medicine Source Type: news

Translator was diagnosed with stage-four cancer after she dismissed her cough as 'part of winter' 
Magdalena Bujalski, 22, of Winnipeg, Canada, was told her cough was likely just bronchitis, until an X-ray revealed an unusual mass on her right lung. She was diagnosed with Non-Hodgkin Lymphoma. (Source: the Mail online | Health)
Source: the Mail online | Health - August 5, 2019 Category: Consumer Health News Source Type: news

Antibiotic stewardship: duration of antibiotic treatment for common infections frequently exceeds guideline recommendations
A large cross-sectional study of UK prescribing data found that the duration of antibiotic prescriptions for common infections in primary care frequently exceeded national guideline recommendations. The most common reason for antibiotic prescribing was for respiratory infections, and more than 80% of prescriptions for acute cough and bronchitis, acute sore throat, acute otitis media and acute exacerbations of COPD were for longer than recommended. Substantial reductions in antibiotic exposure can be achieved by prescribing antibiotics in line with NICE and Public Health England guidance on managing common infections. (Sour...
Source: Current Awareness Service for Health (CASH) - July 12, 2019 Category: Consumer Health News Source Type: news

Medical News Today: Emphysema vs. chronic bronchitis
Emphysema and chronic bronchitis are both respiratory conditions that fall under the classification of chronic obstructive pulmonary disease, or COPD. The symptoms may overlap. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 1, 2019 Category: Consumer Health News Tags: Respiratory Source Type: news

Preventing Antibiotic Resistance: Look to the Livestock Industry
Among the major drivers of the Antimicrobial Resistance crisis is the misuse and overuse of antibiotics in livestock and feed. Credit: Germán Miranda/IPS. By Tharanga YakupitiyageUNITED NATIONS, May 21 2019 (IPS) Antimicrobial resistance is quickly becoming a global crisis and risks reversing a century of progress in health. Some organisations have already geared up and are tackling the issue from its roots. In a new report, the United Nations Interagency Coordination Group (IACG) on Antimicrobial Resistance estimates that antibiotic resistance could cause 10 million deaths each year by 2050. Already, drug-resistan...
Source: IPS Inter Press Service - Health - May 21, 2019 Category: International Medicine & Public Health Authors: Tharanga Yakupitiyage Tags: Development & Aid Featured Global Headlines Health IPS UN: Inside the Glasshouse North America Regional Categories Sustainability TerraViva United Nations Antimicrobial resistance (AMR) WHO Source Type: news

The hand-held breath test that spots lung diseases in just one minute 
The device is being trialled on NHS patients with asthma and chronic obstructive pulmonary disease (COPD), a group of lung conditions including emphysema and chronic bronchitis. (Source: the Mail online | Health)
Source: the Mail online | Health - May 21, 2019 Category: Consumer Health News Source Type: news